ATAI Life Sciences NV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: NL0015000DX5
USD
4.05
-0.01 (-0.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Y-mAbs Therapeutics, Inc.
Enanta Pharmaceuticals, Inc.
ATAI Life Sciences NV
Generation Bio Co.
Sutro Biopharma, Inc.
Akebia Therapeutics, Inc.
Assertio Holdings, Inc.
Praxis Precision Medicines, Inc.
Immuneering Corp.
Lifecore Biomedical, Inc.
AEON Biopharma, Inc.

Why is ATAI Life Sciences NV ?

1
Poor Management Efficiency with a low ROE of 0%
  • The company has reported losses. Due to this company has reported negative ROE
2
Flat results in Mar 26
  • PRE-TAX PROFIT(Q) Lowest at USD -31.15 MM
  • NET PROFIT(Q) Lowest at USD -31.15 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 74.25%, its profits have risen by 20.6%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ATAI Life Sciences NV for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
ATAI Life Sciences NV
63.31%
2.32
82.00%
S&P 500
25.22%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
38.47%
EBIT Growth (5y)
-258.35%
EBIT to Interest (avg)
-48.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.54
Sales to Capital Employed (avg)
0.01
Tax Ratio
2.98%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.96%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.48
EV to EBIT
-8.29
EV to EBITDA
-8.34
EV to Capital Employed
-28.35
EV to Sales
235.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-39.23%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
EPS(Q)

Highest at USD -0.08

-8What is not working for the Company
PRE-TAX PROFIT(Q)

Lowest at USD -31.15 MM

NET PROFIT(Q)

Lowest at USD -31.15 MM

Here's what is working for ATAI Life Sciences NV

EPS
Highest at USD -0.08
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for ATAI Life Sciences NV

Pre-Tax Profit
At USD -31.15 MM has Fallen at -41.68%
over average net sales of the previous four periods of USD -21.98 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -31.15 MM has Fallen at -41.45%
over average net sales of the previous four periods of USD -22.02 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Pre-Tax Profit
Lowest at USD -31.15 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD -31.15 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)